Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-<i>d</i>]pyrimidine scaffold
Daniel J. Baillache, Asier Unciti‐Broceta
Abstract
Pyrazolo[3,4-<italic>d</italic>]pyrimidines have become of significant interest for the medicinal chemistry community as a privileged scaffold for the development of kinase inhibitors to treat a range of diseases, including cancer.
Topics & Concepts
ScaffoldPyrimidineKinaseChemistryCancer researchMedicineStereochemistryBiochemistryBiomedical engineeringQuinazolinone synthesis and applicationsBiochemical and Molecular ResearchChronic Lymphocytic Leukemia Research